MAP
MICROBA FPO [MAP]
Healthcare · ASX Small Cap
$0.0830 -2.4%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -1First seen: 2026-02-25
Score Breakdown
Technical42
Catalyst50
Sentiment50
Fundamental64
Momentum26
Risk Gate50
Active Signals
Bullish Signals
- Stochastic oversold
- VPT accumulation divergence (bullish)
- Volatility contracting (breakout setup)
- Low cash runway (4 quarters) - dilution risk
- 4C filed 2026-01-28
- Low P/S ratio (3.3x)
- EPS estimates revised upward (+10pts)
- Near 52-week low (10% of range)
- Small-cap ($20-100M)
- CANSLIM S: Tight float (35%)
- CANSLIM I: Institutional ownership (21%)
- Severe 12-1 momentum decline (-52%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Breakdown below 20-day support
- Negative 5-day momentum (-4.6%)
- Below 200-day MA (long-term downtrend)
- Revenue declining (-14%)
- Piotroski F-Score weak (3/9)
- Deeply negative margins (-95%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-14%)
Recent Catalysts
NONE Appendix 4D & FY26 Interim Report
LOW Q2 FY26 Quarterly Investor Presentation & Webinar
LOW Q2 FY26 Quarterly Activities Report & Appendix 4C
LOW Details of Q2 FY26 Quarterly Report, Appendix 4C & Webinar
Recent ASX Announcements
| 2026-02-25 | Appendix 4D & FY26 Interim Report PRICE SENSITIVE |
| 2026-01-28 | Q2 FY26 Quarterly Investor Presentation & Webinar PRICE SENSITIVE |
| 2026-01-28 | Q2 FY26 Quarterly Activities Report & Appendix 4C PRICE SENSITIVE |
| 2026-01-21 | Details of Q2 FY26 Quarterly Report, Appendix 4C & Webinar |
Key Metrics
$51.8M
Market Cap
192K
Avg Volume
1.3x
Vol Ratio
$0.07 — $0.23
52-Week Range
N/A
Short Interest
4 qtrs
Cash Runway
-40.5%
ROE
-95.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 35% |
| L | Leader vs Laggard | pass | RS: 3 |
| I | Institutional Sponsorship | pass | Inst: 21% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #88 of 119 · Sector avg: 51
View all Healthcare signals →